Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Labs Doing Deals, Stock Headed To $62
Forbes
Saturday, March 3, 2012 - 11:33am
tags:
Abbott Laboratories
Why Some Trends Matter, Even When There Is A Hiccup
Seeking Alpha
Saturday, March 3, 2012 - 11:32am
tags:
R&D
JP Morgan analyst upgrades Eli Lilly to 'Neutral'
Yahoo/AP
Saturday, March 3, 2012 - 11:31am
tags:
Eli Lilly
Pfizer Is A Better Buy For Longer-Term Investors
Seeking Alpha
Saturday, March 3, 2012 - 11:30am
tags:
Pfizer
GlaxoSmithKline Antitrust Probe Dropped by EU Commission
Bloomberg
Saturday, March 3, 2012 - 11:29am
tags:
GSK, antitrust
We Think Pfizer Is Ridiculously Cheap
Seeking Alpha
Saturday, March 3, 2012 - 11:24am
tags:
Pfizer
Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Saturday, March 3, 2012 - 11:24am
tags:
Isis Pharmaceuticals, Kynamro, Genzyme, Sanofi
Watson launches generic version of Abbott's Prometrium
Yahoo/theflyonthewall.com
Saturday, March 3, 2012 - 11:22am
tags:
Watson Pharmaceuticals, Prometrium, generics
FDA Approval Practically A Done Deal For Keryx And AEterna Zentaris
Seeking Alpha
Saturday, March 3, 2012 - 11:20am
tags:
Keryx, Aeterna Zentaris, perifosine
Roche's Illumina Bid Gets More Time
Yahoo/Zacks
Saturday, March 3, 2012 - 11:17am
tags:
Roche, Illumina, M&A
IBD Tech Stock Screen: 5 Top Meds Start With Questcor
Investors.com
Saturday, March 3, 2012 - 11:15am
tags:
Questcor Pharmaceuticals, Alexion, Celgene, ViroPharma, Cubist Pharmaceuticals
This Drugmaker Is Covering All Its Bills
Motley Fool
Saturday, March 3, 2012 - 11:14am
tags:
Spectrum Pharmaceuticals
9 Biotech Stocks With Significant Liquidity Growth
Seeking Alpha
Saturday, March 3, 2012 - 11:12am
tags:
Corcept Therapeutics, Hi Tech Pharmacal, Questcor Pharmaceuticals, Myriad Genetics, QLT Inc, Valeant Pharmaceuticals, Rigel Pharmaceuticals, Techne, Vivus
Can Drug Maker Questcor Stage A Healthy Climb?
Investors.com
Saturday, March 3, 2012 - 11:09am
tags:
Questcor Pharmaceuticals
Affymax rises on analyst view of anemia drug
Yahoo/AP
Saturday, March 3, 2012 - 11:09am
tags:
Affymax, peginesatide, Epogen, anemia
4 Small-Cap, High-Risk, High-Reward Bio-Pharmas
Seeking Alpha
Friday, March 2, 2012 - 10:40am
tags:
Astex, BioSante, Discovery Labs, Galena Biopharma, OncoVista Innovative Therapies, Spectrum Pharmaceuticals
Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Friday, March 2, 2012 - 10:37am
tags:
earnings, Isis Pharmaceuticals, Kynamro
Genzyme gets FDA OK to ship Fabry drug
Mass High Tech
Friday, March 2, 2012 - 10:20am
tags:
FDA, Fabry's disease, Genzyme, Fabrazyme
Roger Perlmutter’s Parting Thoughts on Amgen
Xconomy
Friday, March 2, 2012 - 10:19am
tags:
Amgen, R&D, Roger Perlmutter
Chinese pharmas feel the squeeze of healthcare reform
Fierce Pharma
Friday, March 2, 2012 - 10:19am
tags:
China, healthcare reform, antibiotics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.